Sanofi : Sanofi Offers to Acquire Medivation for $52.50 Per Share in Cash
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Medivation (MDVN) Expected to Reject Sanofi (SNY) Bid; Sanofi May Abandon Effort - Source
April 28, 2016 12:31 PM EDTMedivation (Nasdaq: MDVN) is expected to reject Sanofi's (NYSE: SNY) $52.50 per share proposal to takeover the company, according to a source familiar with the situation.
Morgan Stanley is also expected to advise Sanofi (NYSE: SNY) to abandon the takeover effort.
Shares of Medivation are up over 8.5 percent.
... MoreSanofi Has Room for Higher Medivation (MDVN) Bid, Credit Suisse Says; Deal Could Be 7% Accretive in 2020 at $80
April 28, 2016 10:33 AM EDTCredit Suisse analyst Kennen MacKay weighs in on Medivation (NASDAQ: MDVN) after Sanofi launched a $52.50/share hostile bid.
The firm's recent takeover analysis suggested MDVN could be worth $55/share to Sanofi and beleives their conservative estimates indicate Sanofi has more... More
Medivation (MDVN) Affirms Receipt of $52.50/Share Takeover Offer from Sanofi (SNY); Will Review
April 28, 2016 9:13 AM EDTMedivation, Inc. (NASDAQ: MDVN) confirmed that it has received an unsolicited, non-binding proposal from Sanofi to acquire all outstanding shares of Medivation common stock for $52.50 in cash.
On April 15, 2016, Medivation's Board of Directors received a private letter from Sanofi making an indicative,... More
